65 related articles for article (PubMed ID: 38708507)
1. [Identification of key genes in Wilms tumor based on high-throughput RNA sequencing and their impacts on prognosis and immune responses].
Gao Z; Lin J; Hong P; Hu Z; Dong J; Shi Q; Tian X; Liu F; Wei G
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):727-738. PubMed ID: 38708507
[TBL] [Abstract][Full Text] [Related]
2. CCNB1 is a novel prognostic biomarker and promotes proliferation, migration and invasion in Wilms tumor.
Xiang B; Chen ML; Gao ZQ; Mi T; Shi QL; Dong JJ; Tian XM; Liu F; Wei GH
BMC Med Genomics; 2023 Aug; 16(1):189. PubMed ID: 37592341
[TBL] [Abstract][Full Text] [Related]
3. [CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis].
Li Y; Wu D; Wei C; Yang X; Zhou S
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1509-1518. PubMed ID: 34755666
[TBL] [Abstract][Full Text] [Related]
4. Using Elevated Cholesterol Synthesis as a Prognostic Marker in Wilms' Tumor: A Bioinformatic Analysis.
He Y; Cui X; Lin Y; Wang Y; Wu D; Fang Y
Biomed Res Int; 2021; 2021():8826286. PubMed ID: 33628817
[TBL] [Abstract][Full Text] [Related]
5. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
Chen Y; He J; Jin T; Zhang Y; Ou Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatical analysis of the key differentially expressed genes for screening potential biomarkers in Wilms tumor.
Cai L; Shi B; Zhu K; Zhong X; Lai D; Wang J; Tou J
Sci Rep; 2023 Sep; 13(1):15404. PubMed ID: 37717078
[TBL] [Abstract][Full Text] [Related]
7. The Detection of Immunity against WT1 and SMAD4
Koya T; Niida Y; Togi M; Yoshida K; Sakamoto T; Ura H; Togi S; Kato T; Yamada S; Sugiyama H; Koido S; Shimodaira S
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293034
[TBL] [Abstract][Full Text] [Related]
8. Immune-related gene signature associates with immune landscape and predicts prognosis accurately in patients with Wilms tumour.
Tian XM; Xiang B; Jin LM; Mi T; Wang JK; Zhanghuang C; Zhang ZX; Chen ML; Shi QL; Liu F; Lin T; Wei GH
Front Immunol; 2022; 13():920666. PubMed ID: 36172369
[TBL] [Abstract][Full Text] [Related]
9. Identification of a 12-Gene Signature and Hub Genes Involved in Kidney Wilms Tumor
Huang G; Mao J
Front Oncol; 2022; 12():877796. PubMed ID: 35480093
[TBL] [Abstract][Full Text] [Related]
10. δ-Catenin Participates in EGF/AKT/p21
Shen Y; Lee HJ; Zhou R; Kim H; Chen G; Cho YC; Kim K
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069970
[TBL] [Abstract][Full Text] [Related]
11. Mediator subunit MED1 is required for E2A-PBX1-mediated oncogenic transcription and leukemic cell growth.
Lee YL; Ito K; Pi WC; Lin IH; Chu CS; Malik S; Cheng IH; Chen WY; Roeder RG
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33542097
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor promotes glioblastoma cell death under glucose deprivation via upregulation of xCT (SLC7A11).
Yamamoto M; Teramoto K; Katoh H
Cell Signal; 2021 Feb; 78():109874. PubMed ID: 33285240
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]